🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models

RecruitingNAAges 40 Years - 90 YearsAllIstituti Clinici Scientifici Maugeri SpA
NCT07906769 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This multicenter study aims to characterize the language profiles of patients with various neurodegenerative diseases, including Alzheimer's disease (AD), Primary Progressive Aphasia (PPA), behavioral variant Frontotemporal Dementia (bvFTD), Dementia with Lewy Bodies (DLB), and Parkinson's disease (PD), using artificial intelligence (AI) models. By analyzing speech and language data collected during remote neuropsychological assessments, the researchers intend to identify objective linguistic biomarkers suitable for early and differential diagnosis, overcoming the limitations of traditional, invasive, and costly diagnostic tools. The project will develop and validate an AI-driven pipeline to provide scalable and individualized linguistic profiles, ultimately supporting personalized treatment strategies and improving clinical workflow efficiency in the Italian population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Participants with neurodegenerative diseases Inclusion criteria Diagnosis of mild cognitive impairment due to Alzheimer's disease (AD), primary progressive aphasia (PPA), behavioral variant frontotemporal dementia (bvFTD), dementia with Lewy bodies (DLB), or Parkinson's disease (PD). Age 40-85 years. Italian native speaker. Able to provide informed consent. Exclusion criteria Mini-Mental State Examination (MMSE) score below 15. Other neurological or psychiatric diagnoses, including cerebrovascular disease documented by MRI or CT. Severe, uncorrected hearing or visual impairment. Clinical Dementia Rating (CDR) score above 1. Healthy controls Inclusion criteria Italian native speaker. Matched to the patient groups for age, sex, and education level. Exclusion criteria History of systemic, neurological, or psychiatric disease. Substance abuse. Family history of neurodegenerative disease. MMSE score below 27/30.
💊

What it tests

  • Speech and language Test to support clinical diagnosis
📍

Where

1 site
Istituti Clinici Scientifici Maugeri IRCCS Bari
Bari, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy